ReviewZeitschrift fur Rheumatologie2026
Turner syndrome as a state of increased autoimmune susceptibility: evidence from rheumatic diseases.
Review in Zeitschrift fur Rheumatologie, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Turner syndrome (TS) is a chromosomal disorder of females due to the partial or complete absence of an X chromosome. Growing evidence suggests a significant association between TS and autoimmune disorders, especially rheumatic diseases like juvenile idiopathic arthritis (JIA) and systemic lupus erythematosus (SLE). Recognition of this association is important for early detection, timely intervention, and avoidance of complications. The aim of this narrative review is to analyze the association between TS and rheumatic diseases in terms of epidemiological, clinical, and pathophysiological aspects as well as therapeutic options. The narrative review was performed by combining information from published case reports, case series, and population-based studies reporting on the association of TS with autoimmune rheumatic diseases. Juvenile idiopathic arthritis was the most frequently described rheumatic disease in TS, mostly as oligoarticular but also as severe polyarticular forms. Systemic lupus erythematosus was less common, but most patients had severe systemic disease with lupus nephritis. Other manifestations were psoriatic arthritis; ankylosing spondylitis in adult and pediatric cases; and systemic sclerosis as a very rare exception, likely reflecting the scarcity of reported cases rather than a defined protective effect in TS. A population-based study revealed that women with TS are at a profoundly increased risk of autoimmune rheumatic diseases as compared to the general female population. In conclusion, these findings suggest increased autoimmune susceptibility in Turner syndrome and underscore the need for heightened clinical awareness. Current evidence remains limited, underscoring the need for heightened clinical awareness rather than routine screening strategies.
Indexed as
Identifiers
41973124What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.